本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
JAKARTA, Indonesia, April 11, 2023 /PRNewswire/ -- ASEAN Finance Ministers and Central Bank Governors reiterated their joint commitment to maintaining financial stability and advancing financial integration, against an uncertain economic outlook that could impact economic growth momentum in the ASEAN region. That was the key takeaway of the ASEAN Finance Ministers and Central Bank Governors Meeting (AFMGM) hosted collaboratively by the Ministry of Finance and Bank Indonesia on 31st March 2023 in Nusa Dua, Bali. 13 high-level meetings were held with Central Bank Governors and Finance Ministers as well as Deputies. "We believe ASEAN must aim to be a region with robust, inclusive, and sustainable economic growth. Economic growth has and will always be the story of ASEAN. To ensure that this will be continuous, we must strengthen ASEAN's capacity to respond to the previous challenges, but most importantly the current and new challenges that we are all seeing today, and the expected challenges in the next twenty years. ASEAN remains a bright spot in the global economy where the region offers more promising prospects compared to a bleaker global outlook." conveyed Minister of Finance of Republic Indonesia, Sri Mulyani Indrawati. ASEAN collectively has a high economic growth and macroeconomic stability. The ASEAN-5 economies together grew by 5.3% last year, and collectively forecasted to grow by 4.6% this year and increase to 5.6% in 2024. The meeting was attended by Finance Ministers and Central Bank Governors from nine ASEAN countries (Brunei Darussalam, Cambodia, Indonesia, Lao People's Democratic Republic, Malaysia, the Philippines, Singapore, Thailand, Vietnam) and representatives from six international organisations (the Asian Development Bank, ASEAN+3 Macroeconomic Research Office, International Monetary Fund, Financial Stability Board, Bank for International Settlement, World Bank). At the AFMGM, members welcomed the theme of Indonesia's ASEAN Chairmanship in 2023, 'ASEAN Matters: Epicentrum of Growth", which has three strategic thrusts: (i) recovery and rebuilding, (ii) the digital economy, and (iii) sustainability. ASEAN members underlined the importance of strong collaboration and cooperation to contain the lingering risks that may pose a threat to the regional economy, welcoming Indonesia's 2023 Priority Economic Deliverables (PEDs) including pandemic preparedness, infrastructure finance, international taxation, customs cooperation, digital financial inclusion for MSMEs and sustainable finance. The outcomes of the 1st AFMGM discussion will be reported to the 42nd ASEAN Summit in May 2023 in Labuan Bajo. A 2nd AFMGM also will be held in August 2023, in Jakarta.
Contract enables Van Gelder to start importing MEXT MEATS products from Japan, and selling in European markets starting from April 2023, having Bidfood and Van der Valk Hotel as the first customers. TOKYO, April 10, 2023 /PRNewswire/ -- NEXT MEATS Co., Ltd. a Japanese subsidiary of NEXT MEATS Holdings, Inc. (OTC Market in the US listed corporation as "NXMH") Tokyo based food-tech venture company and Dr. FOODS Co., Ltd. a group company of NEXT MEATS Co., Ltd. hosted the exclusive tasting event with Van Gelder (Founded in Netherlands in 1953), inviting Bidfood (Shareholder Van Gelder) and Van der Valk Hotel in Netherlands for the mutual distribution of its products in European Markets. At Van Gelder's HQ in Ridderkerk, Netherlands, the executive chef of NEXT MEATS Co., Ltd. prepared 8 course vegan meals using the newest non-GMO soybean protein based alternative meats product named "Next Short Rib 2.0" and "Next Tuna" (Products of NEXT MEATS Co., Ltd.) along with "Vegan Foie Gras" and "Vegan Caviar" (Products of Dr. FOODS Co., Ltd.) finished up with "NEXT Ice Cream" as the vegan desert by demonstrating delectable versatility of the products. There were over 30 participants for this event including the owner, top management, and executive chefs of Van der Valk Hotel (The largest Dutch hospitality chain operates over 80 hotels in EU), and Bidfood (International broad-line foodservice conglomerate, listed on the JSE, South Africa). Followed by this event, NEXT MEATS Co., Ltd. and Van Gelder sighed the exclusive distribution contract which enable them to start importing MEXT MEATS products from Japan, and selling in European markets starting from April 2023, having Bidfood and Van der Valk Hotel as the first customers. This is a major milestone for our group companies as it makes our entrée into European markets with "Next Short Rib 2.0". Van Gelder is a very modern fruit and vegetable supplier and family business. They have been delivering fresh potatoes, vegetables and fruit daily for more than 65 years. To achieve this, Van Gelder controls all of the supply chain, from source to serving. Van Gelder connects growers to customers and has the highest turnover rate in the market. In 2022 they created a new plant based assortment, which they will continue expanding. Van Gelder www.vangeldernederland.nl Krommeweg 10, 2988 CB Ridderkerk, The Netherlands https://twitter.com/VanGelderNL T +31 (0)180 33 60 00 info@vangeldernederland.nl https://www.facebook.com/VanGelderNederland https://www.youtube.com/user/VanGelderNL Bidfood Corporation Limited known as Bidcorp and Bidfood is an international broad-line foodservice group, listed on the JSE, South Africa, and present in developed and developing economies in five continents.https://www.bidfood.com Van der Valk Hotel is a Dutch international hospitality chain run by the Van der Valk family. It is the largest Dutch hospitality chain, with more than 65 locations in the Netherlands and more than 15 in other countries.https://www.valk.com/en NEXT MEATS Co., Ltd. a Japanese subsidiary of NEXT MEATS Holdings, Inc. (OTC Market in the U.S.A. listed corporation as "NXMH") is Tokyo based food-tech venture company that has been devoted for the research, development and in-house production of premium Japanese-style alternative meat products made with non-GMO soy bean protein since 2020. The range of products started from the world's first plant-based Yakiniku Short-Rib and Skirt-Steak to Beef Bowl, Chicken, Burger Patties, Pork, Tuna and Milk for both professional and family use. NEXT MEATS Co., Ltd. continue to develop new products and grow business both in Japan and around the world by venturing into the global vegan market with a proposal of "NEXT Food" choices from Japan. Dr. FOODS Co., Ltd. a Japanese subsidiary of Dr. FOODS Inc. (OTC Market in the U.S.A. listed corporation as "DRFS") is Tokyo based food-tech venture and spin-off company of Next Meats Co., Ltd that has been focusing on the research and development of cultured foods. The proprietary technologies which combined with over 1000 years of Japanese traditional fermented foods culture called "KOJI" (rice malt) gave a breakthrough invention of the world's first vegetable based "Vegan Foie Gras". For further information, please contact the following. Photo Download Link: https://www.dropbox.com/sh/sr7wzkki9tyg1jp/AABT6bqY1bd4UzMfu72OW-kGa?dl=0 Shimizu Building 2nd Floor, CEO: Koichi Ishizuka https://www.nextmeats.global 34-16 Shinjuku 1 Chome, COO: Mitsuru Anthony Ueno https://www.facebook.com/NextMeats/ Shinjuku-Ku, ueno@nextmeats.co.jp https://www.instagram.com/nextmeatsjapan/ Tokyo 160-0022 JAPAN +81-90-2988-0477 +81-3-6457-7612
CMM and PwC Malaysia aim to drive awareness of sustainability value propositions throughout the supply chain KUALA LUMPUR, Malaysia, April 11, 2023 /PRNewswire/ -- Capital Markets Malaysia ("CMM"), an affiliate of the Securities Commission Malaysia, and PwC Malaysia ("PwC"), today launched "Corporate Malaysia's Journey Towards a Sustainable Supply Chain", a report, assessing the current state of Malaysia's supply chains through a sustainability lens. The report highlights the opportunities to be gained from greater engagement of small-to-medium-sized enterprises ("SMEs"), which are typically the largest contributors to the supplier ecosystem. To date, SMEs make up the majority of suppliers for public- listed companies ("PLCs"), contributing 38% of the nation's gross domestic product ("GDP") and accounting for 48% of the national employment rate. Malaysia is at a crossroads, with mounting pressures to address sustainability considerations within supply chains as the country's major trading partners step up their focus on net zero commitments, while increasing regulatory scrutiny and consumer concerns continue to play a check and balance role. Developed against the backdrop of Corporate Malaysia's transition towards a low carbon economy, the report explores how sustainable supply chains can be a new growth lever for the nation, by improving Malaysia's attractiveness as an investment destination. The report presents three key areas that PLCs will need to consider for the adoption of greater supply chain sustainability - governance and integration, engagement and incentive, as well as data and reporting. Navina Balasingam, General Manager of CMM Navina Balasingam, General Manager of CMM said, "PLCs will need to lead by example given their capacity and exposure to international market expectations. While Malaysia's PLCs have made significant progress in incorporating ESG principles as part of their business strategy, there is still much to be done to strengthen sustainability practices within their supply chains. This report finds that of Bursa Malaysia's Top 100 companies, while 80% have ESG governance and oversight in place to develop sustainable supply chains, only 55% have incorporated supply chain risks as part of their overall corporate risks and strategy. As for the unlisted space which are predominantly made up of SMEs, the absence of a standardised lens to evaluate and measure these companies does present a challenge for corporations seeking to measure and reduce their Scope 3 emissions. With this report, we aim to provide examples of initiatives and measures that can be taken by both private and public sector actors to support sustainability within supply chains." The report features case studies of Malaysian companies that have exemplified efforts in improving their supply chain sustainability by engaging SME suppliers. These initiatives include working with suppliers to build dashboards for traceability of raw materials or emissions, driving collaborative relationships that uplift suppliers' income opportunities, and developing incentive programmes to encourage desired sustainable behaviours, amongst others. Andrew Chan, SEA Sustainability & Climate Change Leader of PwC Malaysia Andrew Chan, South East Asia's Sustainability and Climate Change Leader, PwC Malaysia commented, "As an active trading nation, Malaysia is not alone in facing hurdles around supply chain sustainability amidst the greater push globally around disclosure and uplift of supply chain practices. Considering how intricately linked companies' sustainability performance is with their supply chains, companies will need to rethink their relationship with suppliers beyond contracted transactions, to inspire suppliers to adopt sustainability practices and enhance their performance. We're also seeing a number of initiatives by the public sector to support the transition including working with SMEs to encourage adoption of low carbon practices, which is certainly encouraging. However, this will need to be backed up by investment in the right infrastructure and policies to allow Malaysian companies to truly transform their supply chains and build long term value for their stakeholders beyond helping local suppliers to meet the stringent sustainability requirements needed to participate in global supply chains." Recognising the challenging operating backdrop today, CMM is developing a Simplified ESG Disclosure Guide ("Guide") specially curated for SMEs, scheduled to launch in the fourth quarter of 2023. The Guide will provide practical guidance and the baseline disclosures expected of SMEs in relation to ESG aligned with international standards, to encourage greater transparency and improve the quality of SMEs' ESG disclosures. Navina commented, "We recognise the urgent need to enable and support the SMEs' journey by defining and paving the best path forward towards impactful change. In addition to ensuring alignment in the disclosure indicators with global disclosure frameworks, the Guide will further bring value to the overall process of enabling supply chain partners to meet their sustainability commitments." For more information on the report, please visit: https://www.capitalmarketsmalaysia.com/corporate-malaysias-journey-towards-a-sustainable-supply-chain/
ABU DHABI,UAE, April 11, 2023 /PRNewswire/ -- Ryse Energy, a global leader in decentralized renewable energy systems having sold or installed more than 4,000 units for clients worldwide, announces it has raised a $15 million growth funding round. Ryse Energy Hybrid Renewable Energy System in an off-grid location The round was led by RWE Energy Transition Investments, an investment vehicle of RWE Supply & Trading GmbH, the energy trading arm of the global renewable energy company RWE. The investment will enable Ryse Energy to accelerate its international growth and enter untapped markets, expand its technology offerings, and continue to diversify its business model into energy-as-a-service. Ryse Energy is a primary manufacturer of high-performance small wind turbine technologies and provides a range of additional renewable energy systems, including solar and energy storage. The company has manufacturing facilities in the UK and Spain, with sales offices across the globe including the USA, Europe, the UAE and India. Ryse Energy's renewable systems can be used as standalone technologies, grid-connected or off-grid with energy storage, or hybridized to create bespoke and reliable hybrid renewable solutions. The company works across a variety of sectors, from decarbonizing critical infrastructure such as telecoms and oil & gas networks, to marine and agriculture applications, to community power for rural electrification. "RWE is one of the largest renewable energy companies in the world and we are thrilled to have them as our lead investor and strategic partner," said Alistair Munro, CEO & Founder of Ryse Energy. "This investment will enable us to accelerate our growth and expand our product offering, while continuing to deliver innovative decentralized renewable energy systems to our customers around the world, at the same time reducing greenhouse gas emissions and client energy costs." "We are excited to support Ryse Energy in its mission to provide clean, renewable energy solutions to customers around the world," said Costas Papamantellos, Managing Director & Head of RWE Energy Transition Investments. "We believe that Ryse Energy has the potential to be a major force for good in reducing greenhouse gas emission in remote locations, and providing reliable and sustainable energy access to the over one billion people who currently do not have access globally. We look forward to working with the Ryse Energy and supporting its growth and expansion." The new funding will enable Ryse Energy to enter untapped markets such as North America, where community power and displacing diesel are key focus areas, and Africa, where energy access and powering critical infrastructure such as healthcare and telecoms are strategic priorities. In addition, the company will be hiring globally to keep up with current and future demand. Ryse Energy will also invest in its current technologies to become certified for specific target markets and in addition, the funding will enable Ryse Energy to expand its manufacturing capacity in strategic locations, with the company currently reviewing additional manufacturing locations in the USA, the UAE and India. About Ryse Energy: Ryse Energy is an impact-driven, innovative, decentralized renewable energy technology company with more than 4,000 installations across all seven continents. We are a primary manufacturer of high-performance small wind turbines, with a range of products from micro to medium capacity. Our portfolio of wind technology is the most diverse and advanced in the sector. We offer wind and solar as standalone technologies either grid-connected or off-grid with energy storage, and hybridize our wind technology with solar PV and energy storage to create bespoke and reliable hybrid renewable solutions across a variety of sectors, from decarbonizing infrastructure such as telecoms and O&G, to community power for rural electrification. Website | LinkedIn About RWE: RWE Energy Transition Investments is an investment vehicle of RWE Supply & Trading GmbH with a mandate to manage a diverse portfolio of Private Equity type financial investments in companies and assets that support the Energy Transition. RWE Supply & Trading GmbH is a wholly owned subsidiary of RWE AG, an international energy company leading the way to a green energy world. With an extensive investment and growth strategy, the company will expand its green generation capacity to 50 gigawatts internationally by 2030 by investing more than €50 billion gross for this purpose. RWE employs around 19,000 people worldwide and has a clear target: to get to net zero by 2040. Further information is available at www.rwe.com Ryse Energy Hybrid Renewable Energy System in an off-grid location
LEIDEN, Netherlands, April 11, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the first commercial shipments of Joenja® (leniolisib) to patients in the United States. Joenja®, an oral, selective PI3Kδ inhibitor, is the first and only treatment approved in the U.S. for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare and progressive primary immunodeficiency, in adult and pediatric patients 12 years of age and older. Under the terms of Pharming's 2019 exclusive license agreement with Novartis for leniolisib, the corresponding first commercial sale of Joenja® triggers a $10 million milestone payment by Pharming to Novartis. Stephen Toor, Chief Commercial Officer of Pharming, commented: "We are pleased to announce that the first Joenja® shipments to patients, with payor reimbursement, were delivered approximately two weeks following FDA approval, achieving an important milestone for patients suffering with APDS. We look forward to making Joenja® widely available across the U.S. as the first and only approved treatment for patients with APDS." About Activated Phosphoinositide 3-Kinase δ Syndrome (APDS) APDS is a rare primary immunodeficiency that was first characterized in 2013. APDS is caused by variants in either one of two identified genes known as PIK3CD or PIK3R1, which are vital to the development and function of immune cells in the body. Variants of these genes lead to hyperactivity of the PI3Kδ (phosphoinositide 3-kinase delta) pathway, which causes immune cells to fail to mature and function properly, leading to immunodeficiency and dysregulation.1,2,3 APDS is characterized by a variety of symptoms, including severe, recurrent sinopulmonary infections, lymphoproliferation, autoimmunity, and enteropathy.4,5 Because these symptoms can be associated with a variety of conditions, including other primary immunodeficiencies, it has been reported that people with APDS are frequently misdiagnosed and suffer a median 7-year diagnostic delay.6 As APDS is a progressive disease, this delay may lead to an accumulation of damage over time, including permanent lung damage and lymphoma.4-7 A definitive diagnosis can be made through genetic testing. APDS affects approximately 1 to 2 people per million worldwide. About Joenja® (leniolisib) Joenja® (leniolisib) is an oral small molecule phosphoinositide 3-kinase delta (PI3Kẟ) inhibitor approved in the US as the first and only targeted treatment of activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS) in adult and pediatric patients 12 years of age and older. Joenja® inhibits the production of phosphatidylinositol-3-4-5-trisphosphate, which serves as an important cellular messenger and regulates a multitude of cell functions such as proliferation, differentiation, cytokine production, cell survival, angiogenesis, and metabolism. Results from a randomized, placebo-controlled Phase II/III clinical trial demonstrated clinical efficacy of Joenja® in the co-primary endpoints; demonstrating statistically significant impact on immune dysregulation and normalization of immunophenotype within these patients, and interim open label extension data has supported the safety and tolerability of long-term Joenja® administration.8 Leniolisib is currently under regulatory review by the European Medicines Agency, with plans to pursue further regulatory approvals in the UK, Canada, Australia and Japan. Leniolisib is also being evaluated in a Phase III clinical trial in children aged 4 to 11 with APDS, with a further trial planned in children aged 1 to 6 years with APDS. For information about Joenja®, visit: Joenja.com About Pharming Group N.V. Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific. For more information, visit www.pharming.com and find us on LinkedIn. Forward-looking Statements This press release may contain forward-looking statements. Forward-looking statements are statements of future expectations that are based on management's current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in these statements. These forward-looking statements are identified by their use of terms and phrases such as "aim", "ambition", ''anticipate'', ''believe'', ''could'', ''estimate'', ''expect'', ''goals'', ''intend'', ''may'', "milestones", ''objectives'', ''outlook'', ''plan'', ''probably'', ''project'', ''risks'', "schedule", ''seek'', ''should'', ''target'', ''will'' and similar terms and phrases. Examples of forward-looking statements may include statements with respect to timing and progress of Pharming's preclinical studies and clinical trials of its product candidates, Pharming's clinical and commercial prospects, and Pharming's expectations regarding its projected working capital requirements and cash resources, which statements are subject to a number of risks, uncertainties and assumptions, including, but not limited to the scope, progress and expansion of Pharming's clinical trials and ramifications for the cost thereof; and clinical, scientific, regulatory and technical developments. In light of these risks and uncertainties, and other risks and uncertainties that are described in Pharming's 2021 Annual Report and the Annual Report on Form 20-F for the year ended December 31, 2021, filed with the U.S. Securities and Exchange Commission, the events and circumstances discussed in such forward-looking statements may not occur, and Pharming's actual results could differ materially and adversely from those anticipated or implied thereby. All forward-looking statements contained in this press release are expressly qualified in their entirety by the cautionary statements contained or referred to in this section. Readers should not place undue reliance on forward-looking statements. Any forward-looking statements speak only as of the date of this press release and are based on information available to Pharming as of the date of this release. Pharming does not undertake any obligation to publicly update or revise any. Inside Information This press release relates to the disclosure of information that qualifies, or may have qualified, as inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation. References 1. Lucas CL, et al. Nat Immunol. 2014;15(1):88-97. 2. Elkaim E, et al. J Allergy Clin Immunol. 2016;138(1):210-218. 3. Nunes-Santos C, Uzel G, Rosenzweig SD. J Allergy Clin Immunol. 2019;143(5):1676-1687. 4. Coulter TI, et al. J Allergy Clin Immunol. 2017;139(2):597-606. 5. Maccari ME, et al. Front Immunol. 2018;9:543. 6. Jamee M, et al. Clin Rev Allergy Immunol. 2019;May 21. 7. Condliffe AM, Chandra A. Front Immunol. 2018;9:338. 8. RAO VK, et al Blood. 2023 Mar 2;141(9):971-983. For further public information, contact: Pharming Group, Leiden, The NetherlandsMichael Levitan, VP Investor Relations & Corporate CommunicationsT: +1 (908) 705 1696 Heather Robertson, Investor Relations & Corporate Communications ManagerE: investor@pharming.com FTI Consulting, London, UKVictoria Foster Mitchell/Alex Shaw/Amy ByrneT: +44 203 727 1000 LifeSpring Life Sciences Communication, Amsterdam, The NetherlandsLeon MelensT: +31 6 53 81 64 27E: pharming@lifespring.nl US PREthan MetelenisE: Ethan.Metelenis@precisionvh.comT: +1 (917) 882 9038 EU PRClaire DobbsE: claire.dobbs@solarishealth.com T: +44 7864 640093
Two new Board Members to join DEKRA SE: Petra Finke (55) to become Chief Digitalization Officer (CDO) as of July 1, 2023, Peter Laursen (47) appointed as Chief Operation Officer (COO) with immediate effect. They both complete the DEKRA SE Board of Management together with Stan Zurkiewicz as CEO and Wolfgang Linsenmaier as CFO. The recent appointments result from significant changes made by DEKRA in both its Board of Management composition and organization, as the company seeks to accelerate its transformation and facilitate the execution of its Focus Strategy 2025. The newly created CDO role will focus on enhancing DEKRA's existing service portfolio and introducing new advanced digital services in the light of the ongoing digital transformation. The newly created COO role is dedicated to strengthening DEKRA's global position, improving the company's business results, and better serving the needs of its customers across the globe. Stefan Kölbl, Chairman of the Supervisory Board of DEKRA: "DEKRA's vision is to become the leading global force in safety, security, and sustainability. The recent changes in the composition of the Board of Management are designed to advance our strategic growth plans and accelerate the pace of execution." TOKYO, April 11, 2023 /PRNewswire/ -- DEKRA appointed two new members to its Board of Management today: Petra Finke (55), currently Global CIO Rhenus Freight Logistics and CEO of Rhenus Freight Network GmbH, will join the company as Chief Digitalization Officer (CDO) on July 1, 2023, while Peter Laursen (47) will fill the role of Chief Operation Officer (COO) with immediate effect. Stefan Kölbl, Chairman of the Supervisory Board of DEKRA: "DEKRA's vision is to become the leading global force in safety, security, and sustainability. The recent changes in the composition of the Board of Management are designed to advance our strategic growth plans and accelerate the pace of execution. Petra Finke and Peter Laursen are the perfect choice for these new roles, and we are glad to welcome them as our new board members. We are convinced they will do great in their new responsibility." Petra Finke (55) has been working with Rhenus Group for over 20 years, most recently as Global CIO Rhenus Freight Logistics and CEO of Rhenus Freight Network GmbH. She was responsible for global IT and digitalization, and in this role successfully managed the transformation of the company's heterogeneous IT and process landscape into a distributed, cloud-based digital ecosystem. Furthermore, she established Rhenus Freight Network GmbH as the central IT service provider and advisor for the global network, while developing digital customer solution to optimize logistics value chains. In her newly created role as CDO of DEKRA, Petra Finke will pursue the company's target to fully leverage the business potential of digitalization. DEKRA expects digital services to play a crucial role in the TIC industry (Testing, Inspection and Certification), and it is set to develop its service portfolio accordingly. Petra Finke will focus on improving existing services, as well as creating reliable services for DEKRA's focus business areas future mobility, sustainability, and cyber security, by deploying the use of cutting-edge tech like AI and remote services. Peter Laursen (47) has been employed at DEKRA for the past 10 years. He has an outstanding track record in business development, turning Denmark's DEKRA Academy into the country's undisputed market leader. In addition, he significantly expanded the range of services beyond trainings, providing for two-digit sales growth over the past years. Being responsible for the Region of North-West Europe, he successfully turned around underperforming businesses navigated external challenges such as impacts of the current geopolitical situation and inflation as well as supply chain bottlenecks. As DEKRA's new COO, he will oversee the company's six business regions which comprise legal entities and operations in 60 countries on all continents, as well as Group Marketing & Sales. He will be responsible for expanding DEKRA's global footprint, especially in the strategic growth regions of North America and Asia. Working with the company's business regions, he will match DEKRA's strong service portfolio with regional demands and work towards achieving the regions' strategic and financial ambitions. "I look forward to working closely with Petra Finke and Peter Laursen to deliver the best customer experience in our industry, across the globe. Their leadership qualities, expertise, and track record of success will be invaluable as we continue to evolve our business and accelerate our digital transformation," said Stan Zurkiewicz, Chairman of the Board of Management and CEO of DEKRA. Stan Zurkiewicz, Chairman of the Management Board DEKRA e.V. and DEKRA SE CEO Petra Finke, as of July 1, 2023, Member of the Management Board DEKRA SE CDO Stefan Kölbl, President of the Presidential Board of DEKRA e.V. and Chairman of the Supervisory Board of DEKRA SE Peter Laursen, Member of the Management Board DEKRA SE COO and Head of Region North-West Europe Wolfgang Linsenmaier, Member of the Management Board DEKRA e.V. and DEKRA SE CFO, HR and Organizational Excellence About DEKRA DEKRA has been active in the field of safety for almost 100 years. Founded in 1925 in Berlin as Deutscher Kraftfahrzeug-Überwachungs-Verein e.V., it is today one of the world's leading expert organizations. DEKRA SE is a subsidiary of DEKRA e.V. and manages the Group's operating business. In 2022, DEKRA will generate preliminary sales totaling almost EUR 3.7 billion. The company currently employs over 48,000 people (as of 30.09.2022) in approximately 60 countries on all continents. With qualified and independent expert ser-vices, they work for safety on the road, at work and at home. These services range from vehicle inspection and expert appraisals to claims services, industrial and building inspections, safety consultancy, testing and certification of products and systems, as well as training courses and temporary work. The vision for the company's 100th birthday in 2025 is that DEKRA will be the global partner for a safe, secure, and sustainable world. With a platinum rating from EcoVadis, DEKRA is now in the top one percent of sustainable businesses ranked.
A12 藝術空間
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
